vTv Therapeutics SG&A Expense (Quarterly) Trends

vTv Therapeutics Inc (VTVT)

23.63 -0.07 (-0.29%) USD | NASDAQ | May 03, 16:00

23.70 +0.06 (+0.28%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	2.569M
September 30, 2023	2.544M
June 30, 2023	3.309M
March 31, 2023	3.485M
December 31, 2022	2.388M
September 30, 2022	2.634M
June 30, 2022	1.831M
March 31, 2022	5.348M
December 31, 2021	5.716M
September 30, 2021	2.221M
June 30, 2021	2.242M
March 31, 2021	2.164M
December 31, 2020	2.035M
September 30, 2020	1.071M
June 30, 2020	1.695M
March 31, 2020	2.45M
December 31, 2019	1.989M
September 30, 2019	1.77M
June 30, 2019	2.392M
March 31, 2019	2.386M

Date	Value
December 31, 2018	2.073M
September 30, 2018	2.158M
June 30, 2018	2.737M
March 31, 2018	2.255M
December 31, 2017	2.937M
September 30, 2017	2.567M
June 30, 2017	3.005M
March 31, 2017	2.824M
December 31, 2016	2.252M
September 30, 2016	2.401M
June 30, 2016	2.672M
March 31, 2016	2.581M
December 31, 2015	2.37M
September 30, 2015	2.415M
June 30, 2015	2.297M
March 31, 2015	1.995M
December 31, 2014	2.14M
September 30, 2014	1.592M
June 30, 2014	2.858M
March 31, 2014	5.127M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.071M

Minimum

Sep 2020

5.716M

Maximum

Dec 2021

2.624M

Average

2.388M

Median

Dec 2022

SG&A Expense (Quarterly) Benchmarks